Early Stability of the Delta-TT Cup With Polyethylene Insert Versus a Ceramic Insert. A RSA Study.

Osteoarthrosis Clinical Trial

— RSA-DELTA-TT  

Official title:

Early Stability of the Delta-TT Cup With Polyethylene Insert Compared to the Delta-TT Cup With Ceramic Insert. A Randomised RSA Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03093038
• Other study ID #: NL44230.100.13 - v1.0
• Status: Completed
• Phase: N/A
• Start date: May 2014
• Est. completion date: May 2021

Study information

• Verified date: October 2021
• Source: JointResearch
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to study the stability of the Delta-TT cup with polyethylene insert and the Delta-TT cup with ceramic insert both combined with the H-MAX femoral stem by means of RSA to assess whether the differences in stiffness of the cup will have an influence on incorporation and mechanical stability.

It is hypothesized that there will be more micromotion on the short-term (<2 years) in the patients with the ceramic insert because of the higher stiffness, however, all components will be considered stable on the short and long-term.

Description:

Rationale: Roentgen Stereophotogrammetric Analysis (RSA) is a very accurate measurement technique used to obtain micromotion of the implants relative to inserted tantalum markers in the surrounding bone. Using RSA, long-term predictions of prosthetic loosening can be made based on a two years follow-up. Therefore, it is recommended to analyse all (new) prosthetic components by means of RSA.

Objective: The goal of this study is to study in a randomised trial the stability of the Delta-TT cup with polyethylene insert and the Delta-TT cup with ceramic insert both combined with the H-MAX femoral stem by means of RSA to assess whether the differences in stiffness of the cup will have an influence on incorporation and mechanical stability. It is hypothesized that there will be more micromotion on the short-term (<2 years) in the patients with the ceramic insert because of the higher stiffness, however, all components will be considered stable on the short and long-term. Secondary goal is to compare the stability of the C2 femoral stem, to the H-MAX femoral stem as well as to compare it to relevant migration results of similar stems from the literature. These RSA results will contribute to knowledge about the early stability and long-term prosthetic loosening of these cementless stems.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: May 2021
• Est. primary completion date: February 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients scheduled to undergo primary total hip replacement.

• Patient is able to understand the meaning of the study and is willing to sign the ethical committee approved, study-specific Informed Patient Consent Form.

• Ability and willingness to follow instructions and to return for follow-up evaluations.

• The subject is a male or non-pregnant female between 18 and 75 years of age.

Exclusion Criteria:

• The subject is morbidly obese, defined as Body Mass Index (BMI) of > 40.

• The subject will be operated bilaterally.

• Patients having a deformity or disease located in other joints than the hip that needs surgery and is limiting their ability to walk.

• The subject has an active or suspected latent infection in or about the hip joint.

• The subject has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.

• The subject has a systemic or metabolic disorder leading to progressive bone deterioration.

• The subject's bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis.

• Female patients planning a pregnancy during the course of the study.

• The patient is unable or unwilling to sign the Informed Consent specific to this study.

• Subject deemed unsuitable for participation in the study based on the investigator's judgement.

Related Conditions & MeSH terms

• Osteoarthritis
• Osteoarthrosis

Intervention

Device:
• H-MAX stem & Delta-TT cup + polyethylene
H-MAX femoral stem & Delta-TT cup with a polyethylene insert
• H-MAX stem & Delta-TT cup + ceramic
H-MAX femoral stem & Delta Delta-TT cup with a Ceramic insert
• C2 stem & Delta-TT cup + ceramic
C2 femoral stem Delta Delta-TT cup with a Ceramic insert

Locations

Country	Name	City	State
Netherlands	Onze Lieve Vrouwe Gasthuis	Amsterdam	Noord Holland

Sponsors (1)

Lead Sponsor	Collaborator
JointResearch

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from Baseline in stability	Stability will be assessed with Roentgen Stereophotogrammetric Analysis (RSA). RSA will be used to determine the micromotion of the femur and cup components with respect to the bone.The RSA data of the components will be described in terms of translational and rotational movements.	2 years
Secondary	Change from Baseline in Quality of Life	Quality of Life (QoL) will be assessed with the questionaire EuroQoL 5D (EQ- 5D)	2 years
Secondary	Change from Baseline in Quality of Life	Quality of Life (QoL) will be assessed with the questionaire EuroQoL 5D (EQ- 5D)	5 years
Secondary	Change from Baseline in Physical Function	Physical Function will be assessed with the Hip disability and Osteoarthritis Outcome Score - Physical Function Short Form (HOOS-PS)	2 years
Secondary	Change from Baseline in Physical Function	Physical Function will be assessed with the Hip disability and Osteoarthritis Outcome Score - Physical Function Short Form (HOOS-PS)	5 years
Secondary	Change from Baseline in Physical Function and Pain	Physical Function will be assessed with the Oxford Hip Score (OHS)	2 years
Secondary	Change from Baseline in Physical Function and Pain	Physical Function will be assessed with the Oxford Hip Score (OHS)	5 years
Secondary	Change from Baseline in Pain	Pain will be assessed with a Numeric Rating Scale (NRS)	2 years
Secondary	Change from Baseline in Pain	Pain will be assessed with a Numeric Rating Scale (NRS)	5 years